Advertisement for orthosearch.org.uk
Bone & Joint Open Logo

Receive monthly Table of Contents alerts from Bone & Joint Open

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Bone & Joint Open at:

Loading...

Loading...

Open Access

Hip

Reduction in rate of implant waste associated with robotic-assisted total hip arthroplasty



Download PDF

Abstract

Aims

Implant waste during total hip arthroplasty (THA) represents a significant cost to the USA healthcare system. While studies have explored methods to improve THA cost-effectiveness, the literature comparing the proportions of implant waste by intraoperative technology used during THA is limited. The aims of this study were to: 1) examine whether the use of enabling technologies during THA results in a smaller proportion of wasted implants compared to navigation-guided and conventional manual THA; 2) determine the proportion of wasted implants by implant type; and 3) examine the effects of surgeon experience on rates of implant waste by technology used.

Methods

We identified 104,420 implants either implanted or wasted during 18,329 primary THAs performed on 16,724 patients between January 2018 and June 2022 at our institution. THAs were separated by technology used: robotic-assisted (n = 4,171), imageless navigation (n = 6,887), and manual (n = 7,721). The primary outcome of interest was the rate of implant waste during primary THA.

Results

Robotic-assisted THA resulted in a lower proportion (1.5%) of implant waste compared to navigation-guided THA (2.0%) and manual THA (1.9%) (all p < 0.001). Both navigated and manual THA were more likely to waste acetabular shells (odds ratio (OR) 4.5 vs 3.1) and polyethylene liners (OR 2.2 vs 2.0) compared to robotic-assisted THA after adjusting for demographic and perioperative factors, such as surgeon experience (p < 0.001). While implant waste decreased with increasing experience for procedures performed manually (p < 0.001) or with navigation (p < 0.001), waste rates for robotic-assisted THA did not differ based on surgical experience.

Conclusion

Robotic-assisted THAs wasted a smaller proportion of acetabular shells and polyethylene liners than navigation-guided and manual THAs. Individual implant waste rates vary depending on the type of technology used intraoperatively. Future studies on implant waste during THA should examine reasons for non-implantation in order to better understand and develop methods for cost-saving.

Cite this article: Bone Jt Open 2024;5(8):715–720.

Take home message

Robotic-assisted total hip arthroplasties (THAs) wasted a smaller proportion of acetabular shells and polyethylene liners than navigation-guided and manual THAs.

Individual implant waste rates vary depending on the type of technology used intraoperatively.

Introduction

Implant waste during total hip arthroplasty (THA) represents a significant cost and burden to the USA healthcare system.1,2 The annual cost of wasted hip arthroplasty implants to hospitals across the USA was estimated to be USD $36,019,000 in a study published in 2010.1 Taking into account a rapidly ageing population and the rising demand for primary THA,3-6 this cost is only expected to continue increasing over the next few decades.1

Robotic-assisted techniques are becoming increasingly popular among surgeons performing THA.7-9 Some studies have shown that, compared to navigation-guided and conventional manual procedures, robotic-assisted THA facilitates increased precision with component positioning.7-11 In turn, these technical advantages can lead to smaller leg-length discrepancies,9,12 greater bone stock preservation,13,14 fewer postoperative complications,15-17 and, in some series, better patient-reported outcomes and fewer revision surgeries.7,17-19

While prior literature has compared the clinical benefits of robotic-assisted, navigation-guided, and manual THA, studies examining these three techniques from an implant waste standpoint are limited. The few studies that have reported on orthopaedic implant waste have typically focused on waste from orthopaedic trauma procedures or total knee arthroplasty, and have reported the average volume and weight of implant waste per surgical case as opposed to rates and types of implants wasted.20-22 Therefore, the primary aim of this study was to determine the rate of implant waste associated with robotic-assisted, navigation-guided, and manual THA. The secondary aims were to determine the effect of surgeon experience on the rate of implant waste, to compare the odds of implant waste by technology used while adjusting for demographic and perioperative factors, and to determine the effect of acetabular shell size on the rate of implant waste.

Methods

Patient population

We identified all patients who underwent a primary THA at our institution (Hospital for Special Surgery, New York, USA) between 1 January 2018 and 30 June 2022 and the implants used during these procedures. Partial hip arthroplasty and revision surgeries were excluded. Patients who underwent one primary THA on each side were included in our study and both surgeries were included in the analyses. The study was approved by the Institutional Review Board and conducted in accordance with the ethical standards in the 1964 Declaration of Helsinki.23

Demographic, perioperative, and surgical data

Demographic data and patient-level characteristics, including sex, age, and BMI, were obtained from electronic health records. Perioperative and surgical data such as American Society of Anesthesiologists (ASA) grade,24 date of surgery, surgeon experience at the time of surgery, procedure type (unilateral or bilateral), surgical approach (anterior or posterior), type of technology used intraoperatively (robotics, navigation, or manual), name and units of implants used, and implant status (implanted or wasted) were also retrieved from medical records. All robotic-assisted THAs performed at our institution during the study period used a CT-based robotic arm-assisted system (Mako; Stryker, USA). Navigation technologies used included HipAlign (OrthAlign, USA), Intellijoint HIP (Intellijoint Surgical, Canada), Naviswiss (Naviswiss, Switzerland), and OrthoSensor (OrthoSensor, USA). Implants were manually reviewed and categorized as femoral heads, femoral components, acetabular shells, polyethylene liners, acetabular screws, dome hole covers, dual-mobility (DM) polyethylene-bearing centralizers, cement restrictors, DM liners, cables/wires, or other. Other implants included femoral head sleeve adapters, bone substitutes, and cones. Acetabular shells were further subcategorized by implant size. Surgeon experience was defined as the time between a surgeon’s fellowship graduation date and the date of surgery.

Outcome measures

The primary outcome of interest of this study was the proportion of surgical implant waste during primary THA. The secondary outcome of interest was the proportion of wasted implants by implant type and size.

Patient characteristics and surgical data

We identified 104,420 implants either implanted or wasted during 18,329 primary THAs performed on 16,724 patients by 43 orthopaedic surgeons at a single institution (Hospital for Special Surgery) between 1 January 2018 and 30 June 2022. Of these procedures, 17,938 were unilateral THAs and 391 were simultaneous bilateral THAs (Table I). Navigation guidance and robotic assistance were used in 6,887 and 4,171 procedures, respectively. The remaining 7,271 THAs were performed manually. Mean age at the time of surgery was 63.4 years (12 to 97). Mean BMI was 28.7 kg/m2 (15 to 63). More robotic-assisted, navigation-guided, and manual THAs were performed in females than males. Most patients were white (86%) and were ASA grade II (79%) at the time of surgery. Over 97% of all THAs were unilateral procedures.

Statistical analysis

Descriptive statistics were reported with frequencies and percentages for categorical variables including patient age in ten-year bins, sex, race, BMI with World Health Orginazation (WHO) categories, ASA grades from 0 to IV, surgical procedure (unilateral or bilateral), surgeon experience (< five years, five to ten years, ten to 20 years, and 20+ years), and shell size. Chi-squared test and Fisher’s exact test were used to compare categorical variables between/within three groups (robotics, navigation, or manual) and implant status (implanted or wasted). Multivariate logistic regression analyses were performed to determine if a specific technology assistant was significantly associated with a type of component waste (femoral head, femoral component, acetabular shell, or polyethylene liner), after adjusting for patient BMI, weight, height, age, race, sex, ASA grade, surgeon experience, and surgical approach (anterior or posterior). A p-value ≤ 0.05 was considered statistically significant. All odds ratios (ORs) are reported with 95% CIs. All tests were two-tailed. Statistical analyses were performed using SAS v. 9.4 (SAS Institute, USA) and RStudio v. 1.4.1717 (RStudio, USA).

Table I.

Total hip arthroplasty patient-level characteristics.*

Variable Robotic-assisted (n = 4,171), n (%) Navigation-guided (n = 6,887), n (%) Manual (n = 7,271), n (%)
Age, yrs
< 50 376 (9) 520 (8) 615 (8)
50 to 59 926 (22) 1,652 (24) 1,509 (21)
60 to 69 1,565 (38) 2,734 (40) 2,527 (35)
70 to 79 1,029 (25) 1,594 (23) 1,929 (27)
80+ 275 387 691
BMI, kg/m2
< 18.5 44 (1) 101 (1) 87 (1)
18.5 to 24.9 1,038 (25) 2,259 (33) 1,641 (23)
25 to 29.9 1,504 (36) 2,452 (36) 2,466 (34)
30 to 39.9 1,408 (34) 1,843 (27) 2,581 (35)
40+ 177 (4) 232 (3) 496 (7)
Sex
Male 1,880 (45) 2,748 (40) 3,165 (44)
Female 2,291 (55) 4,139 (60) 4,106 (56)
ASA grade
0 7 (0.2) 29 (0.4) 33 (0.5)
1 174 (4.2) 334 (4.8) 238 (3.3)
2 3,325 (79.7) 5,672 (82.4) 5,615 (77.2)
3 655 (15.7) 846 (12.3) 1,381 (19)
4 10 (0.2) 6 (0.1) 4 (0.1)
THA procedure
Unilateral 4,144 (99) 6,714 (97) 7,080 (97)
Bilateral 27 (1) 173 (3) 191 (3)
  1. *

    Bilateral total hip arthroplasties (THAs) were counted as one case for all patient-level characteristics.

  1. Patients who underwent one primary THA on each hip were counted twice.

  1. ASA, American Society of Anesthesiologists; THA, total hip arthroplasty.

Results

Proportion of implant waste

The overall rate of implant waste for any component was significantly higher for navigation-guided (2.0%) and manual (1.9%) THAs compared to robotic-assisted (1.5%) THAs (both p < 0.001) (Table II). Specifically, robotic-assisted THAs wasted a smaller proportion of femoral components, acetabular shells, and polyethylene liners than navigation-guided and manual THAs (all p < 0.05). In particular, acetabular shell waste was 0.5% in the robotic-assisted group compared to 1.2% in both the navigation-guided and manual groups, respectively. No statistically significant differences were seen in DM polyethylene bearing, centralizer, DM liner, or cables/wires waste.

Table II.

Implant waste for primary total hip arthroplasty components by technology used.

Implant Robotic-assisted (n = 4,171) Navigation-guided (n = 6,887) Manual (n = 7,271) Total (n = 18,329)
Implanted, n Wasted, n Waste, % Implanted, n Wasted, n Waste, % Implanted, n Wasted, n Waste, % Implanted, n Wasted, n Waste, %
Femoral head 4,198 52 1.2 7,060 187 2.6 7,462 114 1.5 18,720 353 1.9
Femoral component 4,198 44 1.0 7,060 111 1.5 7,462 113 1.5 18,720 268 1.4
Acetabular shell 4,198 19 0.5 7,060 89 1.2 7,462 90 1.2 18,720 198 1.0
Polyethylene liner 3,923 63 1.6 6,331 208 3.2 6,069 201 3.2 16,323 472 2.8
Acetabular screw 5,252 104 1.9 3,377 51 1.5 2,254 112 4.7 10,883 267 2.4
Dome hole covers 1,624 72 4.2 2,783 44 1.6 3,112 64 2.0 7,519 180 2.3
DM poly bearing 275 3 1.1 729 12 1.6 1,393 19 1.3 2,397 34 1.4
Centralizer 217 4 1.8 780 7 0.9 819 11 1.3 1,816 22 1.2
Cement restrictor 428 14 3.2 817 10 1.2 519 13 2.4 1,764 37 2.1
DM liners 271 - 0.0 494 5 1.0% 871 5 0.6 1,636 10 0.6
Cables/wires 132 6 4.3 77 7 8.3 113 5 4.2 322 18 5.3
Other 1,370 18 1.3 1,483 28 1.9 831 11 1.3 3,684 57 1.5
Total 26,086 399 1.5 38,051 759 2.0 38,367 758 1.9 102,504 1,916 1.8
  1. DM, dual-mobility.

Effects of surgeon experience on implant waste

Implant waste decreased significantly with increasing surgical experience for navigation-guided (p < 0.001) and manual (p < 0.001) THAs, but not for robotic-assisted THAs (p = 0.420) (Table III). For surgeons with less than 20 years of experience, the use of robotics resulted in lower implant waste rates compared to navigation-guided and manual procedures (all p < 0.001). However, robotic assistance did not result in reductions in implant waste for surgeons who had 20 or more years of experience. The rate of waste did not exceed 2.0% for all experience levels in the robotic-assisted group.

Table III.

Proportion of implant waste by surgeon experience and technology used.

Robotic-assisted Navigation-guided Manual
Experience, yrs Implanted, n Wasted, n Waste, % Implanted, n Wasted, n Waste, % Implanted, n Wasted, n Waste, %
Less than 5 8,521 158 1.8 3,012 97 3.1 1,593 53 3.2
5 to 10 13,317 189 1.4 2,256 68 2.9 6,304 144 2.2
10 to 20 3,750 42 1.1 18,626 386 2.0 10,271 196 1.9
20 or more 498 10 2.0 14,157 208 1.4 20,199 365 1.8

Multivariate analyses

After adjusting for demographic and perioperative factors including BMI, age, race, sex, ASA grade, surgeon experience, and surgical approach, the odds of acetabular shell and polyethylene liner waste were significantly greater for navigation-guided (OR 4.5, 95% CI 2.4 to 8.7 for acetabular shells; OR 2.2, 95% CI 1.5 to 3.1 for polyethylene liners) and manual (OR 3.1, 95% CI 1.7 to 5.8 for acetabular shells; OR 2.0, 95% CI 1.4 to 2.7 for polyethylene liners) THAs compared to robotic-assisted THAs (Table IV). Navigation-guided THAs wasted more femoral heads (OR 1.9, 95% CI 1.2 to 2.9) and femoral components (OR 1.7, 95% CI 1.2 to 2.6) compared to robotic-assisted THAs, but no other significant differences in femoral head and femoral component waste were observed.

Table IV.

Odds of implant waste by technology used adjusted for demographic and perioperative factors.

Outcome Comparison Odds ratio 95% CI p-value*
Acetabular shell wasted Navigation vs robotics 4.5 2.4 to 8.7 < 0.001
Manual vs robotics 3.1 1.7 to 5.8 < 0.001
Navigation vs manual 1.5 1.0 to 2.1 0.047
Polyethylene liner wasted Navigation vs robotics 2.2 1.5 to 3.1) < 0.001
Manual vs robotics 2.0 1.4 to 2.7 < 0.001
Navigation vs manual 1.1 0.8 to 1.5 0.999
Femoral head wasted Navigation vs robotics 1.9 1.2 to 2.9 0.002
Navigation vs manual 1.4 1.0 to 2.0 0.093
Manual vs robotics 1.3 0.9 to 2.0 0.291
Femoral component wasted Navigation vs robotics 1.7 1.2 to 2.6 0.004
Navigation vs manual 1.3 0.9 to 1.9 0.195
Manual vs robotics 1.3 0.9 to 2.0 0.340
  1. *

    Multiple comparisons with Bonferroni correction. All models are adjusted for BMI, age, race, sex, American Society of Anesthesiologists grade, surgeon experience, and surgical approach (anterior or posterior). Bold indicates statistical significance.

Acetabular shell waste by shell size

Further analyses of acetabular shell waste demonstrated that implant waste differed significantly depending on shell size (Table V). Acetabular shell waste for shells 56 mm and larger was greater for navigation-guided and manual THAs compared to robotic-assisted procedures (navigation (1.9%) vs robotic (0.6%); p = 0.005; manual (1.2%) vs robotic (0.6%); p = 0.048). Waste rates for shells 52 mm and smaller did not differ significantly by technology used (all p > 0.05). No significant difference in acetabular shell waste by shell size was observed within groups for robotic-assisted, navigation-guided, and manual procedures.

Table V.

Acetabular shell sizes wasted by technology.

Robotic-assisted Navigation-guided Manual
Acetabular shell size, mm Implanted Wasted Wasted, % Implanted Wasted Wasted, % Implanted Wasted Wasted, %
46 or lower 167 - 0 358 4 1.1 264 4 1.5
48 775 5 0.6 1,296 13 1 1,014 12 1.2
50 450 3 0.7 1,336 20 1.5 1,305 21 1.8
52 1,149 4 0.3 1,571 19 1.2 1,705 14 0.8
54 600 1 0.2 1,138 7 0.6 1,252 15 1.2
56 or higher 1,057 6 0.6 1,361 26 1.9 1,922 24 1.2
Total 4,198 19 0.5 7,060 89 1.3 7,462 90 1.2

Discussion

Understanding the factors that affect orthopaedic implant waste in primary THA may help reduce operating theatre expenditure and eliminate unnecessary costs to our healthcare system, especially as the demand for THA in the USA continues to increase. Though the use of robotics and navigation in THA has become more and more common,15,25 no studies, to the best of our knowledge, have examined and compared the proportion of implant waste during THA by intraoperative technology use and implant type. This study included a large sample of robotic-assisted, navigation-guided, and manual THAs, and identified significant differences in waste rates depending on technology used, implant type, implant size, and surgeon experience. These findings suggest that the use of robotics during primary THA is associated with reduced rates of overall implant waste.

There have been few studies that have reported on overall implant waste rates and costs in hip arthroplasty. Payne et al,2 for instance, analyzed 1,076 THAs performed between June 2012 and May 2013 at a single institution and reported an estimated waste cost of USD$118 per THA. Laurut et al26 examined all hip arthroplasties performed at a French teaching hospital in 2016 and reported higher rates of acetabular shell (6.1%) and polyethylene liner (6.6%) waste compared to our study. It should be noted, however, that both these studies included revision THAs.

Prior studies have also examined the variance in THA implant waste by years of surgical experience and found no significant differences in waste between surgeons with less than ten years of experience, ten to 19 years of experience, and more than 20 years of experience.2 However, these researchers did not stratify THAs by technology used and reported the percentage of cases with implant waste without taking into account how many implants were used in each case. In our study, implant waste decreased with increasing experience for THAs performed manually and with navigation guidance, but not for robotic-assisted THAs. Furthermore, surgeons with less than 20 years of experience who performed robotic-assisted procedures wasted significantly fewer implants compared to those who performed navigation-guided and manual procedures. These findings suggest that the technical features of robotic-assisted surgery may aid less experienced surgeons to more consistently prepare and implant an acetabular component.

We observed a decreased rate of waste for larger acetabular shells 56 mm or greater using robotic assistance compared to navigation or manual technique. We speculate that this observation may be due to the use of a single- or two-stage reaming technique using a robotic arm that is able to maintain trajectory and centre of rotation throughout the reaming process. Conventionally, larger acetabular sizes are prepared with sequential reaming, with each step introducing the possibility of eccentric reaming and suboptimal fit of the acetabular component, which may lead to waste. Taken together with our observations regarding surgeon experience, we suggest that it is the unique technical features of the robotic arm that result in more consistent acetabular preparation, and by extension, decreased acetabular component waste.

This study has limitations. All data were obtained from a single teaching institution and therefore may not be generalizable to all orthopaedic departments across the USA. Nonetheless, our study is impactful in that it incorporates a large sample of robotic-assisted, navigation-guided, and manual THAs and is one of the first studies, to the best of our knowledge, to demonstrate that the use of robotic assistance during primary THAs can effectively reduce implant waste rates. We were not able to fully account for all surgeon-related and technical factors that may result in implant waste. The current study also included a smaller sample of surgeons with 20 or more years of experience who performed robotic-assisted THAs, which may have contributed to the differences in implant waste observed between robotic-assisted and conventional procedures performed by this cohort. Additionally, we did not track the reason for each wasted implant, which could have included unpackaging errors, failed implantation due to patient anatomy, loss of sterility, or incorrect surgical use, among others. Understanding the reason for non-implantation can be helpful for future cost-containment efforts.

Robotic-assisted THAs wasted a smaller proportion of acetabular shells and polyethylene liners than navigation-guided and manual THAs. Individual implant waste rates vary depending on the type of technology used intraoperatively. Future studies on implant waste during THA should examine reasons for non-implantation in order to better understand and develop methods for cost-saving.


Correspondence should be sent to Ryan Cheng. E-mail:

References

1. Zywiel MG , Ulrich SD , Suda AJ , Duncan JL , McGrath MS , Mont MA . Incidence and cost of intraoperative waste of hip and knee arthroplasty implants . J Arthroplasty . 2010 ; 25 ( 4 ): 558 562 . Crossref PubMed Google Scholar

2. Payne A , Slover J , Inneh I , Hutzler L , Iorio R , Bosco JA 3rd . Orthopedic implant waste: analysis and quantification . Am J Orthop (Belle Mead NJ) . 2015 ; 44 ( 12 ): 554 560 . PubMed Google Scholar

3. Bloom DE , Canning D , Lubet A . Global population aging: facts, challenges, solutions and perspectives . Daedalus . 2015 ; 144 ( 2 ): 80 92 . Crossref Google Scholar

4. Kurtz S , Ong K , Lau E , Mowat F , Halpern M . Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030 . J Bone Joint Surg Am . 2007 ; 89-A ( 4 ): 780 785 . Crossref PubMed Google Scholar

5. Kim S . Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997-2004 . Arthritis Rheum . 2008 ; 59 ( 4 ): 481 488 . Crossref PubMed Google Scholar

6. Kurtz S , Mowat F , Ong K , Chan N , Lau E , Halpern M . Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002 . J Bone Joint Surg Am . 2005 ; 87-A ( 7 ): 1487 1497 . Crossref PubMed Google Scholar

7. Bullock EKC , Brown MJ , Clark G , Plant JGA , Blakeney WG . Robotics in total hip arthroplasty: current concepts . J Clin Med . 2022 ; 11 ( 22 ): 6674 . Crossref PubMed Google Scholar

8. Gupta A , Redmond JM , Hammarstedt JE , Petrakos AE , Vemula SP , Domb BG . Does robotic-assisted computer navigation affect acetabular cup positioning in total hip arthroplasty in the obese patient? a comparison study . J Arthroplasty . 2015 ; 30 ( 12 ): 2204 2207 . Crossref PubMed Google Scholar

9. Nawabi DH , Conditt MA , Ranawat AS , et al. Haptically guided robotic technology in total hip arthroplasty: a cadaveric investigation . Proc Inst Mech Eng H . 2013 ; 227 ( 3 ): 302 309 . Crossref PubMed Google Scholar

10. Kamara E , Robinson J , Bas MA , Rodriguez JA , Hepinstall MS . Adoption of robotic vs fluoroscopic guidance in total hip arthroplasty: is acetabular positioning improved in the learning curve? J Arthroplasty . 2017 ; 32 ( 1 ): 125 130 . Crossref PubMed Google Scholar

11. Domb BG , El Bitar YF , Sadik AY , Stake CE , Botser IB . Comparison of robotic-assisted and conventional acetabular cup placement in THA: a matched-pair controlled study . Clin Orthop Relat Res . 2014 ; 472 ( 1 ): 329 336 . Crossref PubMed Google Scholar

12. Nakamura N , Sugano N , Nishii T , Kakimoto A , Miki H . A comparison between robotic-assisted and manual implantation of cementless total hip arthroplasty . Clin Orthop Relat Res . 2010 ; 468 ( 4 ): 1072 1081 . Crossref PubMed Google Scholar

13. Perets I , Mu BH , Mont MA , Rivkin G , Kandel L , Domb BG . Current topics in robotic-assisted total hip arthroplasty: a review . Hip Int . 2020 ; 30 ( 2 ): 118 124 . Crossref PubMed Google Scholar

14. Suarez-Ahedo C , Gui C , Martin TJ , Chandrasekaran S , Lodhia P , Domb BG . Robotic-arm assisted total hip arthroplasty results in smaller acetabular cup size in relation to the femoral head size: a matched-pair controlled study . Hip Int . 2017 ; 27 ( 2 ): 147 152 . Crossref PubMed Google Scholar

15. Emara AK , Zhou G , Klika AK , et al. Is there increased value in robotic arm-assisted total hip arthroplasty? A nationwide outcomes, trends, and projections analysis of 4,699,894 cases . Bone Joint J . 2021 ; 103-B ( 9 ): 1488 1496 . Crossref PubMed Google Scholar

16. Perets I , Walsh JP , Close MR , Mu BH , Yuen LC , Domb BG . Robot-assisted total hip arthroplasty: clinical outcomes and complication rate . Int J Med Robot . 2018 ; 14 ( 4 ): e1912 . Crossref PubMed Google Scholar

17. Ng N , Gaston P , Simpson PM , Macpherson GJ , Patton JT , Clement ND . Robotic arm-assisted versus manual total hip arthroplasty: a systematic review and meta-analysis . Bone Joint J . 2021 ; 103-B ( 6 ): 1009 1020 . Crossref PubMed Google Scholar

18. Domb BG , Chen JW , Lall AC , Perets I , Maldonado DR . Minimum 5-year outcomes of robotic-assisted primary total hip arthroplasty with a nested comparison against manual primary total hip arthroplasty: a propensity score-matched study . J Am Acad Orthop Surg . 2020 ; 28 ( 20 ): 847 856 . Crossref PubMed Google Scholar

19. Clement ND , Gaston P , Bell A , et al. Robotic arm-assisted versus manual total hip arthroplasty . Bone Joint Res . 2021 ; 10 ( 1 ): 22 30 . Crossref PubMed Google Scholar

20. Zywiel MG , Delanois RE , McGrath MS , Ulrich SD , Duncan JL , Mont MA . Intraoperative waste of trauma implants: a cost burden to hospitals worth addressing? J Orthop Trauma . 2009 ; 23 ( 10 ): 710 715 . Crossref PubMed Google Scholar

21. Ast MP , Mayman DJ , Su EP , Gonzalez Della Valle AM , Parks ML , Haas SB . The reduction of implant-related errors and waste in total knee arthroplasty using a novel, computer based, e.Label and compatibility system . J Arthroplasty . 2014 ; 29 ( 1 ): 132 136 . Crossref PubMed Google Scholar

22. Stall NM , Kagoma YK , Bondy JN , Naudie D . Surgical waste audit of 5 total knee arthroplasties . Can J Surg . 2013 ; 56 ( 2 ): 97 102 . Crossref PubMed Google Scholar

23. World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects . 2013 ; 310 ( 20 ): 2191 2194 . Crossref PubMed Google Scholar

24. Saklad M . Grading of patients for surgical procedures . Anesthesiol . 1941 ; 2 ( 5 ): 281 284 . Google Scholar

25. Fontalis A , Raj RD , Kim WJ , et al. Functional implant positioning in total hip arthroplasty and the role of robotic-arm assistance . Int Orthop . 2023 ; 47 ( 2 ): 573 584 . Crossref PubMed Google Scholar

26. Laurut T , Duran C , Pages A , Morin MC , Cavaignac E . What is the cost burden of surgical implant waste? An analysis of surgical implant waste in an orthopedics and trauma surgery department of a French university hospital in 2016 . Orthop Traumatol Surg Res . 2019 ; 105 ( 6 ): 1205 1209 . Crossref PubMed Google Scholar

Author contributions

T. S. Shen: Conceptualization, Investigation, Validation, Formal analysis, Data curation

R. Cheng: Conceptualization, Investigation, Validation, Formal analysis, Data curation, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing

Y. Chiu: Conceptualization, Formal analysis, Data curation, Methodology, Validation, Visualization, Writing – review & editing

A. S. McLawhorn: Conceptualization, Data curation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review & editing

M. P. Figgie: Conceptualization, Data curation, Formal analysis, Validation, Investigation, Resources, Writing – original draft, Writing – review & editing

G. H. Westrich: Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Project administration, Resources, Writing – original draft, Writing – review & editing

Funding statement

The authors received no financial or material support for the research, authorship, and/or publication of this article.

ICMJE COI statement

M. P. Figgie discloses consulting fees from Lima Corporate, Lima USA, and WishBone Medical; support for attending meetings and/or travel from WishBone Medical; and stock or stock options from HS2, Joint Effort ASO, Mekanika, and WishBone Medical, all of which are unrelated to this paper. A. S. McLawhorn declares consulting fees from Globus Medical, unrelated to this work. G. H. Westrich reports support for the present manuscript from Stryker, which is related to this study; and royalties or licenses from Stryker and Exactech; consulting fees from Stryker, Exactech, Medical Device Businesses Services, and Ethicon; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, support for attending meetings and/or travel, and Stock or stock options from Stryker, all of which are unrelated.

Data sharing

The data that support the findings for this study are available to other researchers from the corresponding author upon reasonable request.

Ethical review statement

The study was approved by the Institutional Review Board and conducted in accordance with the ethical standards in the 1964 Declaration of Helsinki.

Open access funding

The authors confirm that the open access funding for this manuscript was self-funded.

Social media

Follow R. Cheng on X @RyanC_43

© 2024 Shen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND 4.0) licence, which permits the copying and redistribution of the work only, and provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc-nd/4.0/